A study of the potential confounding effects of diet, caffeine, nicotine and lorazepam on the stability of plasma and urinary homovanillic acid levels in patients with schizophrenia

Biological Psychiatry

Volumn 40, Issue 12, 1996, Pages 1218-1221

  Donnelly, Craig L ^a   McEvoy, Joseph P ^a,b   Wilson, William H ^a,b   Narasimhachari, Nedarthur ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b John Umstead Hospital   (United States)

Author keywords

caffeine; homovanillic acid; lorazepam; nicotine; schizophrenia

Indexed keywords

CAFFEINE; HOMOVANILLIC ACID; LORAZEPAM; NICOTINE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA;

EID: 0030589558     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00650-8     Document Type: Article

References (14)

1. Amin F, Davidson M, Davis KL (1992): Homovanillic acid measurement in clinical research: A review of methodology. Schizophr Bull 18:123-148.
2. Davidson M, Losonczy MF, Mohs RC, Lesser JC, Powchik P, Freed LF, Davis RM, Mykytyn VV, Davis KL (1987a): Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patients. Neuropsychopharmacology 1:17-23.
3. Davidson M, Giordani AB, Mohs RC, Mykytyn VV, Platt S, Aryan ZS, Davis KL (1987b): Control of exogenous factors affecting Homovanillic acid concentration. Psychiatry Res 20:307-312.
4. Davidson M, Kahn RS, Knott P, Kaminsky R, Cooper M, DuMont K, Apter S, Davis KL (1991): Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations. Arch Gen Psychiatry 48:910-913.
5. Davila R, Zumarraga M, Perea K, Andia I, Friedhoff AJ (1987): Elevation of plasma homovanillic acid level can be detected within four hours after initiation of haloperidol treatment. Arch Gen Psychiatry 837-838.
6. Davila R, Manero E, Zumarraga M, Andia I, Schweitzer JW, Friedhoff AJ (1988): Plasma homovanillic acid as a predictor of response to neuroleptics. Arch Gen Psychiatry 45:564-567.
7. Fri G-G, Wiesel F-A, Sedvall G (1974): Simultaneous quantitation of homovanillic acid and 5-hydroxyindoleacetic acid by mass fragmentography. Life Sci 14:2469-2480.
8. Kendler KS, Mohs RC, Davis KL (1983): The effect of diet and physical activity on plasma homovanillic acid in normal subjects. Psychiatry Res 8:215-223.
9. Konicki PC, Owen RR, Litman RE, Pickar D (1991): The acute effects of central and peripheral-acing dopamine antagonists on plasma HVA in schizophrenic patients. Life Sci 48:1411-1418.
10. McEvoy JP, Hogarty GE, Steingard S (1991): Optimal dose of neuroleptics in acute schizophrenia. Arch Gen Psychiatry 48:739-745.
11. Narasimhachari N. (1983): Use of nonbiological isomers as internal standards for the quantitation of biogenic amines and metabolites by HPLC-EC. Proceedings of the Southwestern Regional Meeting of the American Chemical Society, Charlotte, NC, p 24.
12. Overall JE, Gotham DR (1962): The Brief Psychiatric Rating Scale. Psychol Rep 10:799-812.
13. Pickar D, Labaraca R, Linnoila M, Roy A, Everett D, Paul SM (1984): Neuroleptic induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients. Science 225:954-957.
14. Pickar D, Labaraca R, Doran A, Wolkowitz OM, Roy A, Breier A, Linnoila M, Paul SM (1986): Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Arch Gen Psychiatry 43:669-676.